These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 30387554)

  • 1. Novel flavagline-like compounds with potent Fli-1 inhibitory activity suppress diverse types of leukemia.
    Song J; Yuan C; Yang J; Liu T; Yao Y; Xiao X; Gajendran B; Xu D; Li YJ; Wang C; Liu W; Wen M; Spaner D; Filmus J; Zacksenhaus E; Zhang Y; Hao X; Ben-David Y
    FEBS J; 2018 Dec; 285(24):4631-4645. PubMed ID: 30387554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of diterpenoid compounds that interfere with Fli-1 DNA binding to suppress leukemogenesis.
    Liu T; Xia L; Yao Y; Yan C; Fan Y; Gajendran B; Yang J; Li YJ; Chen J; Filmus J; Spaner DE; Zacksenhaus E; Hao X; Ben-David Y
    Cell Death Dis; 2019 Feb; 10(2):117. PubMed ID: 30741932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A screen for Fli-1 transcriptional modulators identifies PKC agonists that induce erythroid to megakaryocytic differentiation and suppress leukemogenesis.
    Liu T; Yao Y; Zhang G; Wang Y; Deng B; Song J; Li X; Han F; Xiao X; Yang J; Xia L; Li YJ; Plachynta M; Zhang M; Yan C; Mu S; Luo H; Zacksenhaus E; Hao X; Ben-David Y
    Oncotarget; 2017 Mar; 8(10):16728-16743. PubMed ID: 28052010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FLI1 promotes protein translation via the transcriptional regulation of MKNK1 expression.
    Wang C; Song J; Liu W; Yao Y; Kapranov P; Sample KM; Gajendran B; Zacksenhaus E; Hao X; Ben-David Y
    Int J Oncol; 2020 Feb; 56(2):430-438. PubMed ID: 31894299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythroleukemia induction by Friend murine leukemia virus: insertional activation of a new member of the ets gene family, Fli-1, closely linked to c-ets-1.
    Ben-David Y; Giddens EB; Letwin K; Bernstein A
    Genes Dev; 1991 Jun; 5(6):908-18. PubMed ID: 2044959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fli-1 promotes proliferation and upregulates NANOGP8 expression in T-lymphocyte leukemia cells.
    Park SW; Do HJ; Choi W; Kim JH
    Biochimie; 2020 Jan; 168():1-9. PubMed ID: 31626853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective ERK1/2 agonists isolated from Melia azedarach with potent anti-leukemic activity.
    Wang N; Fan Y; Yuan CM; Song J; Yao Y; Liu W; Gajendran B; Zacksenhaus E; Li Y; Liu J; Hao XJ; Ben-David Y
    BMC Cancer; 2019 Aug; 19(1):764. PubMed ID: 31375085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ribavirin Inhibits the Activity of mTOR/eIF4E, ERK/Mnk1/eIF4E Signaling Pathway and Synergizes with Tyrosine Kinase Inhibitor Imatinib to Impair Bcr-Abl Mediated Proliferation and Apoptosis in Ph+ Leukemia.
    Shi F; Len Y; Gong Y; Shi R; Yang X; Naren D; Yan T
    PLoS One; 2015; 10(8):e0136746. PubMed ID: 26317515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of apoptosis by normal and aberrant Fli-1 and erg proteins involved in human solid tumors and leukemias.
    Yi H; Fujimura Y; Ouchida M; Prasad DD; Rao VN; Reddy ES
    Oncogene; 1997 Mar; 14(11):1259-68. PubMed ID: 9178886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The GATA-1 and Spi-1 transcriptional factors bind to a GATA/EBS dual element in the Fli-1 exon 1.
    Barbeau B; Barat C; Bergeron D; Rassart E
    Oncogene; 1999 Sep; 18(40):5535-45. PubMed ID: 10523830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective anticancer effects of a synthetic flavagline on human Oct4-expressing cancer stem-like cells via a p38 MAPK-dependent caspase-3-dependent pathway.
    Emhemmed F; Ali Azouaou S; Thuaud F; Schini-Kerth V; Désaubry L; Muller CD; Fuhrmann G
    Biochem Pharmacol; 2014 May; 89(2):185-96. PubMed ID: 24607276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marsdenia tenacissimae extraction (MTE) inhibits the proliferation and induces the apoptosis of human acute T cell leukemia cells through inactivating PI3K/AKT/mTOR signaling pathway via PTEN enhancement.
    Wang Y; Chen B; Wang Z; Zhang W; Hao K; Chen Y; Li K; Wang T; Xie Y; Huang Z; Tong X
    Oncotarget; 2016 Dec; 7(50):82851-82863. PubMed ID: 27756877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous Fli-1 expression plays an essential role in the proliferation and survival of F-MuLV-induced erythroleukemia and human erythroleukemia.
    Cui JW; Vecchiarelli-Federico LM; Li YJ; Wang GJ; Ben-David Y
    Leukemia; 2009 Jul; 23(7):1311-9. PubMed ID: 19282832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BET bromodomain inhibitors suppress EWS-FLI1-dependent transcription and the IGF1 autocrine mechanism in Ewing sarcoma.
    Loganathan SN; Tang N; Fleming JT; Ma Y; Guo Y; Borinstein SC; Chiang C; Wang J
    Oncotarget; 2016 Jul; 7(28):43504-43517. PubMed ID: 27259270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fli-1b is generated by usage of differential splicing and alternative promoter.
    Dhulipala PD; Lee L; Rao VN; Reddy ES
    Oncogene; 1998 Sep; 17(9):1149-57. PubMed ID: 9764825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FLI-1 inhibits differentiation and induces proliferation of primary erythroblasts.
    Pereira R; Quang CT; Lesault I; Dolznig H; Beug H; Ghysdael J
    Oncogene; 1999 Feb; 18(8):1597-608. PubMed ID: 10102630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms and anti-cancer aspects of the medicinal phytochemicals rocaglamides (=flavaglines).
    Li-Weber M
    Int J Cancer; 2015 Oct; 137(8):1791-9. PubMed ID: 24895251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-mediated inhibition of Fli-1 for the treatment of leukemia.
    Li YJ; Zhao X; Vecchiarelli-Federico LM; Li Y; Datti A; Cheng Y; Ben-David Y
    Blood Cancer J; 2012 Jan; 2(1):e54. PubMed ID: 22829238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of Fli-1 in normal cell function and malignant transformation.
    Truong AH; Ben-David Y
    Oncogene; 2000 Dec; 19(55):6482-9. PubMed ID: 11175364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nemorosone blocks proliferation and induces apoptosis in leukemia cells.
    Díaz-Carballo D; Malak S; Freistühler M; Elmaagacli A; Bardenheuer W; Reusch HP
    Int J Clin Pharmacol Ther; 2008 Aug; 46(8):428-39. PubMed ID: 18793585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.